Project milestone Open Access

In Vitro Critical Appraisal Tool (IV-CAT): Tool Development Protocol

de Vries, Rob; Whaley, Paul

MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="">
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">study quality</subfield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">critical appraisal tool</subfield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">in vitro</subfield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">publishing standards</subfield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">peer-review</subfield>
  <controlfield tag="005">20200120170517.0</controlfield>
  <datafield tag="500" ind1=" " ind2=" ">
    <subfield code="a">The EBTC Scientific Advisory Council were consulted for comment and approval prior to publication of this protocol. Any disputes were arbitrated by the Working Group chairs RdV and PW. The protocol was reviewed by the EBTC Board of Trustees and signed off by EBTC's Executive Director, Dr Katya Tsaioun. After sign-off, this protocol was published in the repository, prior to commencement of screening the search results for the systematic review.</subfield>
  <controlfield tag="001">1493498</controlfield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Lancaster University</subfield>
    <subfield code="0">(orcid)0000-0003-4021-0785</subfield>
    <subfield code="a">Whaley, Paul</subfield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Johns Hopkins University</subfield>
    <subfield code="0">(orcid)0000-0002-3991-0015</subfield>
    <subfield code="4">res</subfield>
    <subfield code="a">Wright, Robert</subfield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">322365</subfield>
    <subfield code="z">md5:358ad4d62369b635303f826a56f5802f</subfield>
    <subfield code="u"> In Vitro CAT Protocol - verson 1-0-0.pdf</subfield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">403201</subfield>
    <subfield code="z">md5:1a04056133ac6d10b51073b4020bbc54</subfield>
    <subfield code="u"> IV-CAT Figure 1 - Study Screening Decision Tree.pdf</subfield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">18924</subfield>
    <subfield code="z">md5:2e9cb8af613fd92409f683014e6227ab</subfield>
    <subfield code="u"> IV-CAT Search Strings.docx</subfield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2018-11-21</subfield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">openaire</subfield>
    <subfield code="o"></subfield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">Evidence Based Toxicology Collaboration, Radboud UMC</subfield>
    <subfield code="a">de Vries, Rob</subfield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">In Vitro Critical Appraisal Tool (IV-CAT): Tool Development Protocol</subfield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u"></subfield>
    <subfield code="a">Creative Commons Attribution Non Commercial 4.0 International</subfield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2"></subfield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;&lt;strong&gt;This document presents the protocol for development of the In-Vitro Critical Appraisal Tool (IV-CAT), intended to help ensure comprehensive and exacting peer-review of &lt;em&gt;in vitro&lt;/em&gt; toxicology studies, and&amp;nbsp;contribute to&amp;nbsp;improving&amp;nbsp;the quality of published &lt;em&gt;in vitro&lt;/em&gt; research. &lt;/strong&gt;Development of the tool is a project of the &lt;a href=""&gt;Evidence Based Toxicology Collaboration&lt;/a&gt; at Johns Hopkins University Bloomberg School of Public Health.&lt;/p&gt;

&lt;p&gt;&lt;em&gt;In vitro&lt;/em&gt; studies are becoming an increasingly important source of data in chemical risk assessment. There are concerns, however, about the methodological quality of these studies and multiple interventions are being undertaken to assess and improve them. Interventions to improve study quality can focus on three target groups: (1) researchers designing, conducting and reporting primary in vitro exposure studies, (2) peer reviewers of journals advising on whether to publish a submitted manuscript and (3) authors of systematic reviews aiming to assess the risk of bias/study quality of the primary in vitro studies included in their review. Given that there are already interventions available or being developed for target groups (1) and (3), IV-CAT focuses on target group (2).&lt;/p&gt;</subfield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">doi</subfield>
    <subfield code="i">isVersionOf</subfield>
    <subfield code="a">10.5281/zenodo.1493497</subfield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.5281/zenodo.1493498</subfield>
    <subfield code="2">doi</subfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">milestone</subfield>
All versions This version
Views 1,2671,268
Downloads 1,2861,286
Data volume 460.3 MB460.3 MB
Unique views 1,0811,082
Unique downloads 825825


Cite as